文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

降钙素原与可溶性CD14亚型对危重成人脓毒症的诊断价值:系统评价与荟萃分析

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.
PubMed 文献 · J Intensive Care · 2019-04-15
一句话结论在危重成人中,降钙素原与可溶性CD14亚型诊断脓毒症的准确性相似(AUC 0.84 vs 0.87),两者均有助于脓毒症早期诊断。

该系统评价与荟萃分析检索MEDLINE、EMBASE和Cochrane CENTRAL,纳入19项观察性研究、共3012例危重成人患者,评估降钙素原与可溶性CD14亚型诊断脓毒症的准确性。汇总受试者工作特征曲线下面积分别为降钙素原0.84、可溶性CD14亚型0.87。降钙素原汇总敏感度0.80(95%CI 0.75–0.84)、特异度0.75(95%CI 0.67–0.81);可溶性CD14亚型汇总敏感度0.84(95%CI 0.80–0.88)、特异度0.73(95%CI 0.61–0.82)。两者敏感度(p=0.48)和特异度(p=0.57)差异均无统计学意义。作者认为两者诊断准确性相似,均有助于危重成人脓毒症的早期诊断及后续降低死亡率。

要点

  • 纳入19项观察性研究、3012例危重成人,降钙素原诊断脓毒症汇总AUC 0.84,可溶性CD14亚型AUC 0.87。
  • 降钙素原汇总敏感度0.80(95%CI 0.75–0.84)、特异度0.75(95%CI 0.67–0.81)。
  • 可溶性CD14亚型汇总敏感度0.84(95%CI 0.80–0.88)、特异度0.73(95%CI 0.61–0.82)。
  • 降钙素原与可溶性CD14亚型敏感度(p=0.48)和特异度(p=0.57)差异均无统计学意义。
  • 作者认为两者诊断准确性相似,均有助于危重成人脓毒症早期诊断及后续降低死亡率。

适用人群与场景

  • 危重成人患者,用于鉴别脓毒症与其他非感染性全身炎症原因。

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析,纳入19项观察性研究(无随机对照试验),共3012例患者。
  • 降钙素原汇总AUC 0.84,汇总敏感度0.80(95%CI 0.75–0.84)、特异度0.75(95%CI 0.67–0.81)。
  • 可溶性CD14亚型汇总AUC 0.87,汇总敏感度0.84(95%CI 0.80–0.88)、特异度0.73(95%CI 0.61–0.82)。
  • 降钙素原与可溶性CD14亚型汇总敏感度比较p=0.48,特异度比较p=0.57,差异均无统计学意义。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入19项观察性研究,无随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为降钙素原与可溶性CD14亚型诊断脓毒症的准确性相似,两者均有助于危重成人脓毒症的早期诊断及后续降低死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early and accurate diagnosis of sepsis is challenging. Although procalcitonin and presepsin have been identified as potential biomarkers to differentiate between sepsis and other non-infectious causes of systemic inflammation, the diagnostic accuracy of these biomarkers remains controversial. Herein, we performed a comprehensive meta-analysis to assess the overall diagnostic value of procalcitonin and presepsin for the diagnosis of sepsis.

METHODS: We searched three electronic databases (MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials) for relevant studies. Two authors independently screened articles on the basis of inclusion and exclusion criteria. The pooled sensitivity, specificity, and summary receiver operating characteristic curves were estimated. The quality of evidence for diagnostic accuracy in absolute effects, i.e., the number of true or false positives and true or false negatives, gave a particular pre-test probability.

RESULTS: We included 19 studies (19 observational studies and no randomized controlled trials) that had enrolled 3012 patients. Analyses of summary receiver operating characteristic curves revealed areas under the receiver operating characteristic curves of 0.84 for procalcitonin and 0.87 for presepsin. The pooled sensitivities and specificities were 0.80 (95% confidence interval 0.75 to 0.84) and 0.75 (95% confidence interval 0.67 to 0.81) for procalcitonin. For presepsin, these values were 0.84 (95% confidence interval 0.80 to 0.88) and 0.73 (95% confidence interval 0.61 to 0.82), respectively. There were no statistically significant differences in both pooled sensitivities (p = 0.48) and specificities (p = 0.57) between procalcitonin and presepsin.

CONCLUSION: Our meta-analysis provided evidence that the diagnostic accuracy of procalcitonin and presepsin in detecting infection was similar and that both are useful for early diagnosis of sepsis and subsequent reduction of mortality in critically ill adult patients.

SYSTEMATIC REVIEW REGISTRATION: The study was registered in PROSPERO under the registration number CRD42016035784.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Kondo Y, Umemura Y, Hayashida K, et al. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care. 2019. PMID: 31016020. doi:10.1186/s40560-019-0374-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。